Mangoceuticals, inc. announces upcoming launch of its sildenafil based mango flavored rapid dissolve ed product

Dallas, texas, june 21, 2023 (globe newswire) -- mangoceuticals, inc. (nasdaq:mgrx) (“mangorx” or the “company”), a company focused on developing, marketing, and selling multiple men's health and wellness products through a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ed) drug, “mango,”, is pleased to announce the upcoming release of its second mango ed product leveraging the company's existing custom compound alongside sildenafil, which is the active ingredient found in viagra™.
MGRX Ratings Summary
MGRX Quant Ranking